Genetic modifiers of sickle cell disease

Cited by (316)

Items 301–316 of 316

1. Dissection of the phenotypic expressivity across a natural population
   Élodie Caudal · 2021 · theses.fr (ABES)
2. Association de nouveaux marqueurs de l'hémolyse intravasculaire aux complications cardiovasculaires du diabète et de la drépanocytose
   Sylvain Le Jeune · 2022
3. Sickle Cell Disease: Can genetic variability influence pregnancy outcomes?
   Catarina Ginete, Carolina Cruz, Mariana Delgadinho, Manuela Mendes, Fernanda Simão, Ligia Alves, Jocelyne Vasconcelos, Paula Borralho, Miguel Brito · 2026 · Blood Cells Molecules and Diseases
4. Genetic suppressors as new therapeutic targets for Mendelian diseases.
   Claire Paltenghi-Peceva, Sabine van Schie, E. Heidari, S. Friend, Jolanda van Leeuwen · 2026 · Trends in Genetics
5. Perspective Chapter: Mapping the Burden – Sickle Cell Disease Epidemiology and Disease Behavior in the Arabian Gulf
   Rehab Yusuf Al-Ansari · 2026 · IntechOpen eBooks
6. Blood Transfusion and ABO Blood Groups in Sickle Cell Disease
   Mortadah Alsalman, Muthana A. Al Sahlawi, Naushad Abid, Khaled Mohamed Amin Elzorkany, Eman Abdallah, Alaa Mustafa Alquraini, Hussain Abduljaleel Alkhalifa, Marwa Mahmoud Shafey, Zaenb Husain Alsalman · 2026 · Medicina
7. Perspective Chapter: Fetal Hemoglobin Modulators
   Vaishali Atmaram Walke · 2026 · IntechOpen eBooks
8. Rigidochromic Fluorophores Identify Single Monomer Mutation on Synthetic Macromolecular Chain
   Huifen Zhu, Huacan Wu, Haizhou Pei, Jie Liu, Bo Chen, Weiguo Huang · 2026 · Angewandte Chemie International Edition
9. Rigidochromic Fluorophores Identify Single Monomer Mutation on Synthetic Macromolecular Chain
   Huifen Zhu, Huacan Wu, Haizhou Pei, Jie Liu, Bo Chen, Weiguo Huang · 2026 · Angewandte Chemie
10. Experimentieren und Online-Lernen im Schüler*innenlabor: Vorstellung des Kurses „Genetik und Evolution des Menschen“
    Maren Panhorst, Merle Katharina Thomas, Norbert Grotjohann · 2026 · Springer eBooks
11. Parvovirus B19 infections in paediatric sickle cell disease patients: Genotype and hydroxyurea treatment influence disease severity
    Matthias Bleeke, Arne Simon, Beate Winkler, Sabine Heine, Anna Eichinger, Ulrich von Both, Meinolf Siepermann, Sonya El Amouri, Arndt Borkhardt, Yvonne Pritschow et al. · 2026 · British Journal of Haematology
12. The Chemist’s Lens of Sickle Cell Disease: Molecular Mechanisms, Biophysical Dynamics, Tissue Pathology, and Emerging Chemical Therapeutics — A Critical Review
    KANAYO SAMUEL OKONJI, Alaba Olanrewaju Daramola, Olufemi Ebenezer Folaranmi, Olugbenga Tosin Alade · 2026 · World Scientific News
13. Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews
    Alvin M Katumba, Carolyn J. Doree, Lise J Estcourt · 2026 · Cochrane Database of Systematic Reviews
14. Multi-omic and Survival Analysis of Acute Chest Syndrome Burden in Sickle Cell Disease
    Anvita Kulshrestha, Melanie E. Garrett, Seyed Mehdi Nouraie, Roberto F. Machado, Victor R. Gordeuk, Mark T. Gladwin, Marilyn J. Telen, Allison E. Ashley‐Koch, NHLBI Trans-Omics for Precision Medicine (TOPMed) · 2026 · medRxiv
15. BindingDB Entry 50013438: PF-07059013: A Noncovalent Modulator of Hemoglobin for Treatment of Sickle Cell Disease.
    BindingDB · 2022 · UC San Diego
16. Hashimoto’s thyroiditis and acute chest syndrome revealing sickle cell anemia in a 32 years female patient
    Marielle Igala, Daniela Nsame, Jennie Dorothée Okuango Guelongo Ova, Siham Cherkaoui, Bouchra Oukkach, Asmae Quessar · 2015 · Pan African Medical Journal